Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.imlet.2020.09.007 http://scihub22266oqcxt.onion/10.1016/j.imlet.2020.09.007 33007369!7524442!33007369     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Immunol+Lett 2020 ; 228 (ä): 38-44 Nephropedia Template TP {{tp|p=33007369|t=2020. "Cytokine storm", not only in COVID-19 patients Mini-review |pdf=|usr=}}{{33007369}} gab.com Text "Cytokine storm", not only in COVID-19 patients Mini-review JO: Immunol Lett http://www.kidney.de/pget.php?&tw=1&pmid=33007369 #FOAvip Cytokine storm is a form of uncontrolled systemic inflammatory reaction activated by a variety of factors and leading to a harmful homeostatic process, even to patient's death. Triggers that start the reaction are infection, systemic diseases and rarely anaphylaxis. Cytokine storm is frequently mentioned in connection to medical interventions such as transplantation or administration of drugs. Presented mini-review would like to show current possibilities how to fight or even stop such a life-threatening, immune-mediated process in order to save lives, not only in COVID-19 patients. Early identification of rising state and multilevel course of treatment is imperative. The most widely used molecule for systemic treatment remains tocilizumab. Except for anti IL-6 treatment, contemporary research opens the possibilities for combination of pharmaceutical, non-pharmaceutical and adjunctive treatment in a successful fight with consequences of cytokine storm. Further work is needed to discover the exact signaling pathways that lead to cytokine storm and to determine how these effector molecules and/or combination of processes can help to resolve this frequently fatal episode of in fl ammation. It is a huge need for all scientists and clinicians to establish a physiological rational for new therapeutic targets that might lead to more personalized medicine approaches. Twit Text FOAVip "Cytokine storm", not only in COVID-19 patients Mini-review ????Immunol Lett http://www.kidney.de/pget.php?&tw=1&pmid=33007369 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33007369 #FOAvip English Wikipedia <ref>{{Cite pmid|33007369}}</ref> "Cytokine storm", not only in COVID-19 patients Mini-review #MMPMID33007369 Lukan N Immunol Lett 2020[Dec]; 228 (ä): 38-44 PMID33007369show ga Cytokine storm is a form of uncontrolled systemic inflammatory reaction activated by a variety of factors and leading to a harmful homeostatic process, even to patient's death. Triggers that start the reaction are infection, systemic diseases and rarely anaphylaxis. Cytokine storm is frequently mentioned in connection to medical interventions such as transplantation or administration of drugs. Presented mini-review would like to show current possibilities how to fight or even stop such a life-threatening, immune-mediated process in order to save lives, not only in COVID-19 patients. Early identification of rising state and multilevel course of treatment is imperative. The most widely used molecule for systemic treatment remains tocilizumab. Except for anti IL-6 treatment, contemporary research opens the possibilities for combination of pharmaceutical, non-pharmaceutical and adjunctive treatment in a successful fight with consequences of cytokine storm. Further work is needed to discover the exact signaling pathways that lead to cytokine storm and to determine how these effector molecules and/or combination of processes can help to resolve this frequently fatal episode of in fl ammation. It is a huge need for all scientists and clinicians to establish a physiological rational for new therapeutic targets that might lead to more personalized medicine approaches. |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |COVID-19/*complications/*therapy[MESH] |Clinical Trials as Topic[MESH] |Cytokine Release Syndrome/*etiology/immunology/pathology/*therapy[MESH] |Humans[MESH] |Immunomodulation[MESH] |Inflammation[MESH]"Cytokine storm", not only in COVID-19 patients Mini-review (epmc).pdf DeepDyve Pubget Overpricing